Pluri Inc. — Director's Dealing 2016

Feb 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2016-02-22

Reporting Person: Aberman Zami (Director, CEO & Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-22	Common Stock	P	5000	$1.33	Acquired	111400	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2118298	Direct